Design and analysis of non-inferiority mortality trials in oncology

  • How do you determine non-inferiority?

    Noninferiority trials are used to assess whether the effect of a new drug is not worse than an active comparator by more than a noninferiority margin.
    If the difference between the new drug and the active comparator does not exceed this prespecified margin, noninferiority can be concluded..

  • How do you interpret a non-inferiority trial?

    Noninferiority trials are used to assess whether the effect of a new drug is not worse than an active comparator by more than a noninferiority margin.
    If the difference between the new drug and the active comparator does not exceed this prespecified margin, noninferiority can be concluded..

  • How do you test for non-inferiority?

    For example, if we are testing for noninferiority with a 5% significance level, we would construct a 90% 2-sided confidence interval and use the lower bound to determine noninferiority.
    Two-sided confidence intervals are usually useful in equivalence testing, where one is interested in the composite hypothesis (3)..

  • What is a non-inferiority study design?

    Noninferiority trials are intended to show that the effect of a new treatment is not worse than that of an active control by more than a specified margin..

  • What is a randomized noninferiority trial?

    Although it is not statistically possible to prove that two treatments are identical, it is possible to determine that a new treatment is not worse than the control treatment by an acceptably small amount, with a given degree of confidence.
    This is the premise of a randomized, noninferiority trial..

  • What is non inferiority in research?

    Noninferiority trials are intended to show that the effect of a new treatment is not worse than that of an active control by more than a specified margin..

  • What is the hypothesis for a non-inferiority trial?

    In a noninferiority trial, the null hypothesis states that the primary end point for the new treatment is worse than that of the active control by a prespeci- fied margin, and rejection of the null hypothesis at a prespecified level of statistical significance permits a conclusion of noninferiority..

  • What is the hypothesis testing for non-inferiority?

    Hypothesis testing in non-inferiority trials
    The null hypothesis in non-inferiority trials is that new treatment is inferior to standard treatment.
    The alternative hypothesis is the new treatment is non-inferior to standard treatment..

  • What is the hypothesis testing in a non-inferiority trial?

    Hypothesis testing in non-inferiority trials
    The null hypothesis in non-inferiority trials is that new treatment is inferior to standard treatment.
    The alternative hypothesis is the new treatment is non-inferior to standard treatment..

  • Although it is not statistically possible to prove that two treatments are identical, it is possible to determine that a new treatment is not worse than the control treatment by an acceptably small amount, with a given degree of confidence.
    This is the premise of a randomized, noninferiority trial.
  • If a new treatment is shown to be non-inferior to standard treatment, all it means is that the new treatment is not worse than the standard treatment by the predetermined non-inferior margin.
    The new treatment may subsequently replace the old standard treatment and be accepted as the new standard treatment.
  • In addition, the sample size of a noninferiority trial is very sensitive to the assumed effect of the new treatment relative to the active control; the sample size can be considerably larger if the two treatments are assumed to be equivalent than if the new treatment is assumed to be slightly more effective than the
In cases where it is appropriate, this paper proposes non-inferiority analyses that do not involve a fixed margin, but can be described as a two confidence 

What is a margin in a noninferiority trial?

There are several applications of the margin in the analysis of noninferiority trials, but the recommended approach by regulators, such as the US Food and Drug Administration (FDA), is to compare the estimated 95% confidence interval (CI) of the new drug vs

the active comparator from the noninferiority trial to a predefined margin 1, 2, 3, 6, 7

What is the analysis of noninferiority?

The analysis of noninferiority depends on the noninferiority margin that is the largest clinically acceptable difference between the test drug and the active comparator 1, 2, 3, 6, 7


Categories

Design and analysis of network
Design and analysis of nuclear power plants
Design and analysis of network algorithms
Design and analysis of nonlinear control systems
Design and analyze secure networked systems answers
Project design and network analysis
Design and analysis of algorithms notes ppt
Design and analysis of algorithms notes aktu
Design and analysis of algorithms viva questions
Design and analysis projects
Design and analysis pdf
Design and analysis perth
Design and analysis projects for mechanical engineering
Design and performance analysis of algorithms
Sampling design and analysis pdf
Algorithm design and analysis pdf
System design and analysis pdf
Algorithm design and analysis process
Algorithms design and analysis part 1
Algorithms design and analysis part 2